Childhood cancer in children with congenital anomalies in Oklahoma, 1997 to 2009

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 106, Issue 7, 2016, Pages 633-642

  Janitz, Amanda E ^a   Neas, Barbara R ^a   Campbell, Janis E ^a   Pate, Anne E ^b   Stoner, Julie A ^a   Magzamen, Sheryl L ^c   Peck, Jennifer D ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b SOUTHWESTERN OKLAHOMA STATE UNIVERSITY   (United States)

^c Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

children; congenital abnormalities; infant; neoplasms; proportional hazards models

Indexed keywords

AGE; ARTICLE; CANCER REGISTRY; CANCER RISK; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; COHORT ANALYSIS; CONGENITAL MALFORMATION; DISEASE ASSOCIATION; FEMALE; GERM CELL TUMOR; HUMAN; LEUKEMIA; LIVER TUMOR; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OKLAHOMA; POPULATION RISK; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOFT TISSUE SARCOMA; CONGENITAL ABNORMALITIES; FOLLOW UP; INFANT; NEOPLASMS; NEWBORN; PRESCHOOL CHILD;

AGE FACTORS; CHILD; CHILD, PRESCHOOL; CONGENITAL ABNORMALITIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASMS; OKLAHOMA; RETROSPECTIVE STUDIES;

EID: 84959524542     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.23494     Document Type: Article

References (39)

1. Agha MM, Williams JI, Marrett L, et al. 2005. Congenital abnormalities and childhood cancer. [see comment]. Cancer 103:1939–1948.
2. Altmann AE, Halliday JL, Giles GG. 1998. Associations between congenital malformations and childhood cancer. A register-based case-control study. Br J Cancer 78:1244–1249.
3. Bjorge T, Cnattingius S, Lie RT, et al. 2008. Cancer risk in children with birth defects and in their families: a population based cohort study of 5.2 million children from Norway and Sweden. Cancer Epidemiol Biomarkers Prev 17:500–506.
4. Botto LD, Flood T, Little J, et al. 2013. Cancer risk in children and adolescents with birth defects: a population-based cohort study. PLoS One 8:e69077.
5. Buffler PA, Kwan ML, Reynolds P, Urayama KY. 2005. Environmental and genetic risk factors for childhood leukemia: appraising the evidence. Cancer Invest 23:60–75.
6. Carozza SE, Langlois PH, Miller EA, Canfield M. 2012. Are children with birth defects at higher risk of childhood cancers? Am J Epidemiol 175:1217–1224.
7. Clericuzio CL. 1999. Recognition and management of childhood cancer syndromes: a systems approach. Am J Med Genet 89:81–90.
8. Davis FG, Bruner JM, Surawicz TS. 1997. The rationale for standardized registration and reporting of brain and central nervous system tumors in population-based cancer registries. Neuroepidemiology 16:308–316.
9. Dawson S, Charles AK, Bower C, et al. 2015. Risk of cancer among children with birth defects: a novel approach. Birth Defects Res A, Clin Mol Teratol 103:284–291.
10. Durmaz A, Durmaz B, Kadioglu B, et al. 2011. The association of minor congenital anomalies and childhood cancer. Pediatr Blood Cancer 56:1098–1102.
11. Fisher PG, Reynolds P, Von Behren J, et al. 2012. Cancer in children with nonchromosomal birth defects. J Pediatr 160:978–983.
12. Greaves M. 2005. In utero origins of childhood leukaemia. Early Hum Dev 81:123–129.
13. Greaves MF, Wiemels J. 2003. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 3:639–649.
14. Heron M. 2013. Deaths: Leading causes for 2010. National Vital Statistics Reports 62.
15. Hitchins MP. 2015. Constitutional epimutation as a mechanism for cancer causality and heritability? Nat Rev Cancer 15:625–634.
16. Hobbs CA, Chowdhury S, Cleves MA, et al. 2014. Genetic epidemiology and nonsyndromic structural birth defects: from candidate genes to epigenetics. JAMA Pediatr 168:371–377.
17. Knudson AG. 2001. Two genetic hits (more or less) to cancer. Nat Rev Cancer 1:157–162.
18. Lee ST, Muench MO, Fomin ME, et al. 2015. Epigenetic remodeling in b-cell acute lymphoblastic leukemia occurs in two tracks and employs embryonic stem cell-like signatures. Nucleic Acids Res 43:2590–2602.
19. Mann JR, Dodd HE, Draper GJ, et al. 1993. Congenital abnormalities in children with cancer and their relatives: results from a case-control study (IRESCC). Br J Cancer 68:357–363.
20. Marshall GM, Carter DR, Cheung BB, et al. 2014. The prenatal origins of cancer. Nat Rev Cancer 14:277–289.
21. Mehes K, Signer E, Pluss HJ, et al. 1985. Increased prevalence of minor anomalies in childhood malignancy. Eur J Pediatrics 144:243–254.
22. Menegaux F, Olshan AF, Reitnauer PJ, et al. 2005. Positive association between congenital anomalies and risk of neuroblastoma. Pediatr Blood Cancer 45:649–655.
23. Merks JHM, Ozgen HM, Koster J, et al. 2008. Prevalence and patterns of morphological abnormalities in patients with childhood cancer. JAMA 299:61–69.
24. Mertens AC, Wen W, Davies SM, et al. 1998. Congenital abnormalities in children with acute leukemia: a report from the Children's Cancer Group. J Pediatr 133:617–623.
25. Mili F, Khoury MJ, Flanders WD, Greenberg RS. 1993a. Risk of childhood cancer for infants with birth defects. I. A record-linkage study, Atlanta, Georgia, 1968–1988. Am J Epidemiol 137:629–638.
26. Mili F, Lynch CF, Khoury MJ, et al. 1993b. Risk of childhood cancer for infants with birth defects. II. A record-linkage study, Iowa, 1983–1989. Am J Epidemiol 137:639–644.
27. Moore SW. 2009. Developmental genes and cancer in children. Pediatr Blood Cancer 52:755–760.
28. Narod SA, Stiller C, Lenoir GM. 1991. An estimate of the heritable fraction of childhood cancer. Br J Cancer 63:993–999.
29. Narod SA, Hawkins MM, Robertson CM, Stiller CA. 1997. Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet 60:474–485.
30. National Birth Defects Prevention Network. 2004. Guidelines for conducting birth defects surveillance. Atlanta, GA: National Birth Defects Prevention Network, Inc.
31. National Program of Cancer Registries. 2012. Registry plus (tm) link plus. Available at: http://www.cdc.gov/cancer/npcr/tools/registryplus/lp.htm. Accessed February 25, 2013.
32. Nishi M, Miyake H, Takeda T, Hatae Y. 2000. Congenital malformations and childhood cancer. Med Pediatr Oncol 34:250–254.
33. Partap S, MacLean J, Von Behren J, et al. 2011. Birth anomalies and obstetric history as risks for childhood tumors of the central nervous system. Pediatrics 128:e652–657.
34. Rankin J, Silf KA, Pearce MS, et al. 2008. Congenital anomaly and childhood cancer: a population-based, record linkage study. Pediatr Blood Cancer 51:608–612.
35. Savitz DA, Ananth CV. 1994. Birth characteristics of childhood cancer cases, controls, and their siblings. Pediatr Hematol Oncol 11:587–599.
36. Soejima H, Higashimoto K. 2013. Epigenetic and genetic alterations of the imprinting disorder Beckwith-Wiedemann syndrome and related disorders. J Hum Genet 58:402–409.
37. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. 2005. International Classification of Childhood Cancer, Third edition. Cancer 103:1457–1467.
38. Windham GC, Bjerkedal T, Langmark F. 1985. A population-based study of cancer incidence in twins and in children with congenital malformations or low birth weight, Norway, 1967–1980. Am J Epidemiol 121:49–56.
39. Zierhut H, Murati M, Holm T, et al. 2011. Association of rib anomalies and childhood cancers. Br J Cancer 105:1392–1395.